Harvard Apparatus Regenerative Technology Price to Free Cash Flow Ratio 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology price to free cash flow ratio from 2013 to 2024. Price to free cash flow ratio can be defined as

Harvard Apparatus Regenerative Technology Price to Free Cash Flow Ratio 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology price to free cash flow ratio from 2013 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$126B
Cencora (COR)$46.2B
ICON (ICLR)$24.1B
DiDi Global (DIDIY)$18.8B
Avantor (AVTR)$18.3B
Natera (NTRA)$15.7B
Revvity (RVTY)$15.1B
Viatris (VTRS)$14.1B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.5B
Medpace Holdings (MEDP)$11B
Charles River Laboratories (CRL)$10.6B
Sonic Healthcare (SKHHY)$8.9B
Doximity (DOCS)$7.5B
HealthEquity (HQY)$6.9B
Bausch + Lomb (BLCO)$6.5B
PACS (PACS)$6.2B
Organon (OGN)$5.3B
Life Times (LTH)$4.9B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4B
Concentras Parent (CON)$2.9B
GoodRx Holdings (GDRX)$2.9B
BrightSpring Health Services (BTSG)$2.5B
Ardent Health Partners (ARDT)$2.5B
Progyny (PGNY)$2.2B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2.1B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.8B